Rua Bioscience Limited (NZE:RUA)
New Zealand
· Delayed Price · Currency is NZD 0.0280
0.00 (0.00%)
At close: Dec 5, 2025
Rua Bioscience Revenue
In the fiscal year ending June 30, 2025, Rua Bioscience had annual revenue of 1.83M NZD with 477.39% growth. Rua Bioscience had revenue of 937.36K in the half year ending June 30, 2025, with 119.43% growth.
Revenue
1.83M
Revenue Growth
+477.39%
P/S Ratio
3.74
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.83M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fisher & Paykel Healthcare Corporation | 2.16B |
| EBOS Group | 13.24B |
| Summerset Group Holdings | 340.08M |
| Ryman Healthcare | 807.48M |
| Oceania Healthcare | 259.60M |
| AFT Pharmaceuticals | 236.25M |
| Pacific Edge | 18.24M |
| Green Cross Health | 528.32M |